Diabetic Retinopathy Screening
Diabetic Retinopathy: Patient Huddle
This activity is supported by an indepentdant medical education grant from Regeneron Pharmaceuticals, Inc.
Diabetic retinopathy is the leading cause of blindness in working-age adults and affects four of every ten people with diabetes. But only half of those who should be screened for diabetic retinopathy are screened, leaving the rest vulnerable to vision loss that is frequently not detected until it is too late. Timely treatment of diabetic retinopathy can reduce the risk of vision loss by 95%.
Now, primary care clinicians can screen their patients with diabetes using a special handheld camera. Images are then securely sent to an ophthalmologist who will interpret the images. Optimizing Disease Management (ODM): Diabetic Retinopathy, a Penn Medicine – Lancaster General Health quality improvement initiative, provides primary care clinicians with the tools to detect diabetic retinopathy in patients who may not otherwise be screened.
This activity is supported by an indepentdant medical education grant from Regeneron Pharmaceuticals, Inc.
Christian Hermansen, MD, MBA
Specialist, Diseases and Surgery of the Retina and Vitreous
Director, Diabetic Eye Care and Macular Degeneration Center at Family Eye Group
Lancaster General Health & Surgery
Lancaster, PA
Michael R. Pavlica, MD
Specialist, Diseases and Surgery of the Retina and Vitreous
Director, Diabetic Eye Care and Macular Degeneration Center at Family Eye Group
Lancaster General Health & Surgery
Lancaster, PA
This activity is supported by an indepentdant medical education grant from Regeneron Pharmaceuticals, Inc.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This Enduring Material activity, Optimizing Disease Management: A Vision for Diabetic Eye Screening, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 08/23/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved for 1.0 AAFP Prescribed credits.
This activity is intended for primary care clinicians and allied health providers who manage patients with type 2 diabetes.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported no financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Faculty / Presenter Reported Financial Relationship
The PIM planners and managers have nothing to disclose.
The following DKB planners and managers Stan Pogroszewski, and Rachel Deerr hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC.
Estimated time to complete each activity: 1.0 hours
Activity 1 Release Date: 8/16/18 Expiration Date: 8/16/19 | Activity 2 Release Date: 8/23/18 Expiration Date: 8/23/19 |
Media: Internet
There are no fees for participation in this CME activity. To receive credit, participants must 1) read the learning objectives and disclosure statements, 2) complete the educational activity and 3) complete the post-test and activity evaluation.
Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above |
Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |
We use cookies to optimize site functionality and give you the best possible experience. Learn more.